Moderna (MRNA) call put ratio 2.4 calls to 1 put after Phase 1 coronavirus vaccine data

Moderna (NASDAQ: MRNA) May weekly call option implied volatility is at 216, June is at 133; compared to its 52-week range of 50 to 172 after Moderna said its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.

You May Also Be Interested In

• UBS Reiterates Neutral Rating on Moderna (MRNA)
• Grab Holdings (GRAB) call put ratio 7.2 calls to 1 put with a focus on November 4 and April 6 calls, share price up 8.2%
• Brinker International (EAT) call put ratio 1 call 1.9 puts as share price up 2.7%